Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial

Francesco Fioretti, Faiez Zannad, Derek Cyr, Kevin J Anstrom, Irina Barash, Marc P Bonaca, Stefano Corda, Anique Ducharme, Justin Ezekowitz, Anuradha Lala, Carolyn S P Lam, Eldrin F Lewis, JoAnn Lindenfeld, Ciaran J McMullan, Robert J Mentz, Marco Metra, Alanna A Morris, Christopher M O’Connor, Piotr Ponikowski, Yogesh N V Reddy, Giuseppe Rosano, Clara Saldarriaga, Michele Senni, James Udelson, Adriaan A Voors, Javed Butler

Open source

DOI
10.1093/ejhf/xuag267
Published
2026-09-16
Container
European Journal of Heart Failure
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ejhf/xuag267,
  title = {Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial},
  author = {Francesco Fioretti and Faiez Zannad and Derek Cyr and Kevin J Anstrom and Irina Barash and Marc P Bonaca and Stefano Corda and Anique Ducharme and Justin Ezekowitz and Anuradha Lala and Carolyn S P Lam and Eldrin F Lewis and JoAnn Lindenfeld and Ciaran J McMullan and Robert J Mentz and Marco Metra and Alanna A Morris and Christopher M O’Connor and Piotr Ponikowski and Yogesh N V Reddy and Giuseppe Rosano and Clara Saldarriaga and Michele Senni and James Udelson and Adriaan A Voors and Javed Butler},
  year = {2026},
  journal = {European Journal of Heart Failure},
  doi = {10.1093/ejhf/xuag267},
  url = {https://doi.org/10.1093/ejhf/xuag267}
}

RIS

TY  - JOUR
TI  - Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial
AU  - Francesco Fioretti
AU  - Faiez Zannad
AU  - Derek Cyr
AU  - Kevin J Anstrom
AU  - Irina Barash
AU  - Marc P Bonaca
AU  - Stefano Corda
AU  - Anique Ducharme
AU  - Justin Ezekowitz
AU  - Anuradha Lala
AU  - Carolyn S P Lam
AU  - Eldrin F Lewis
AU  - JoAnn Lindenfeld
AU  - Ciaran J McMullan
AU  - Robert J Mentz
AU  - Marco Metra
AU  - Alanna A Morris
AU  - Christopher M O’Connor
AU  - Piotr Ponikowski
AU  - Yogesh N V Reddy
AU  - Giuseppe Rosano
AU  - Clara Saldarriaga
AU  - Michele Senni
AU  - James Udelson
AU  - Adriaan A Voors
AU  - Javed Butler
PY  - 2026
JO  - European Journal of Heart Failure
DO  - 10.1093/ejhf/xuag267
UR  - https://doi.org/10.1093/ejhf/xuag267
ER  - 

APA

Fioretti, F., Zannad, F., Cyr, D., Anstrom, K. J., Barash, I., Bonaca, M. P., Corda, S., Ducharme, A., Ezekowitz, J., Lala, A., Lam, C. S. P., Lewis, E. F., Lindenfeld, J., McMullan, C. J., Mentz, R. J., Metra, M., Morris, A. A., O’Connor, C. M., Ponikowski, P., Reddy, Y. N. V., Rosano, G., Saldarriaga, C., Senni, M., Udelson, J., Voors, A. A., & Butler, J. (2026). Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial. European Journal of Heart Failure. https://doi.org/10.1093/ejhf/xuag267

Source records